Anterix(ATEX) - 2025 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 10-Q ______________________ (Mark one) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 For the transition period from __________ to __________ Commission File Number: 001-36827 ______________________ Anterix Inc. OR (Exact name of registrant as specified in its charter) ______________________ o TRANSIT ...